Home News Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth... News Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth despite labour code cost February 9, 2026 FacebookTwitterPinterestWhatsAppLinkedin Shares of Aurobindo Pharma Ltd ended at ₹1,201.25, up by ₹10.10, or 0.85%, on the BSE.Read More RELATED ARTICLESMORE FROM AUTHOR AI AI startup Emergent scales at record speed by letting anyone build apps on their phone News Digital loans in India remains a massive opportunity despite tighter regulations, says investor Mayank Kachhwaha News IRCON Intl Q3 net profit up 16% on higher margins; revenue dips; dividend declared 13,000FansLike9,000FollowersFollowMost PopularAll AllFeaturedAll time popular Two rice company promoters declared fugitive economic offenders in bank fraud... News February 8, 2026 Amazon Will Deploy AI Tools To Speed Up Movie Production In... Uncategorized February 7, 2026 Inside Janitri: The Startup Improving Pregnancy Outcomes with AI & Remote... Brand Posts April 20, 2026 RBI Plans Rs 25,000 Compensation For Cyber Crime/Fraud Victims Uncategorized February 11, 2026 Best Anti-Money Laundering Software: Top AML Solutions for Startups and Enterprises Uncategorized February 9, 2026
